Antibiotic resistance is now a major issue confronting healthcare providers and their patients. Changing antibiotic resistance patterns, rising antibiotic costs and the introduction of new antibiotics have made selecting optimal antibiotic regimens more difficult now than ever before.
Established in 2001, the Johns Hopkins Antimicrobial Stewardship Program is responding to these challenges through education and research. The program mission is to ensure that every patient at the Johns Hopkins Hospital who needs antimicrobial therapy gets optimal drug choice, dose, duration, and route of administration while minimizing resistance development and toxicity.
Faculty Researchers
Sara Cosgrove, MD, MS
Sara Cosgrove, MD, MS is a Professor of Medicine and Epidemiology. Sher serves as the Director of the Antimicrobial Stewardship Program and is an Associate Hospital Epidemiologist at Johns Hopkins Hospital. Dr. Cosgrove’s research interests include epidemiology and outcomes of antimicrobial resistance, development of tools and programs to promote rational use of antimicrobials, prevention of hospital-acquired infections and epidemiology and management of S. aureus bacteremia. Cosgrove Research Dashboard and Publications
Maria Valeria Fabre, MD
Maria Valeria Fabre, MD is an Assistant Professor of Medicine. She serves as the Associate Medical Director of the Adult Antimicrobial Stewardship Program and is an Associate Hospital Epidemiologist at Johns Hopkins Hospital. Her research interests include diagnostic stewardship, development of strategies to promote optimal antibiotic use in acute care, study of the role of front line nurses in stewardship and approaches to improve blood culturing practices. Fabre Research Dashboard and Publications
Sara Keller, MD, MPH, MSHP
Sara Keller, MD, MPH, MSHP is an Assistant Professor of Medicine and is the Director of the Patient Safety and Quality Improvement Pathways for the Osler Medical Training Program. Dr. Keller’s research focuses on outpatient use of antimicrobial therapy and outpatient central venous catheters, particularly improving the quality of outpatient parenteral antimicrobial therapy. Keller Research Dashboard and Publications